Access and Resources

Access and Resources

Reimbursement Support

Photobiomodulation Coding, Billing, and Reimbursement Webinar

Kevin J. Corcoran, Principal

Corcoran & Corcoran
(Presented June 26, 2025)

Corcoran Reimbursement FAQ
MKT-0144_REV_B_VAL_FAQ_PBM_LumiThera_081425.pdf
Corcoran Reimbursement Q & A
MKT-0146_REV_B_VAL_QA_Additional_Discussion_081425.pdf
Advanced Beneficiary Notice Sample
MKT-0145_REV_B_VAL_ABN_CMS_0131_0126_PBM_081525.pdf
Part C Coverage Determination Sample
MKT-0142_REV_B_VAL_Part_C_Coverage_Determination_Request_Form_PBM_081425.docx
Notice of Exclusion from Health Benefits Sample
MKT-0143_REV_B_VAL_NEHB_PBM_081425.pdf
Reimbursement Support References
MKT-0147_REV_A_VAL_Reimbursement_Support_References_061025.pdf

The Valeda Light Delivery System is intended to provide improved visual acuity in patients with best corrected visual acuity of 20/32 through 20/70 and who have dry age-related macular degeneration (AMD) characterized by:

  • The presence of at least 3 medium drusen {> 63 μm and ≤ 125 μm in diameter), or large drusen {> 125μm in diameter), or non-central geographic atrophy, AND
  • The absence of neovascular maculopathy or center-involving geographic atrophy

After about two years, the Valeda Light Delivery System treatment provides improved mean visual acuity of approximately one line of visual acuity (ETDRS) compared to those not receiving the treatment.

As a precaution, patients have not been tested and should not be treated with Valeda if they have any known photosensitivity to yellow light, red light or near-infrared radiation (NIR), or if they have a history of light activated central nervous system disorders (e.g. epilepsy, migraine). In addition, patients should not receive treatment within 30 days of using photosensitizing agents (e.g. topicals, injectables) that are affected by 590, 660, and/or 850 nm light before consulting with their physician.

Refer to the Valeda Light Delivery System User Manual for full Important Safety Information.

Now’s the Time to Talk

Request time with one of our representatives to learn more about Valeda.

Contact Us
Valeda
LumiThera & Valeda have now been acquired by Alcon - You can learn more about Alcon here and more about how Alcon handles Personal Information at: Alcon Privacy Notice